Please login to the form below

Not currently logged in
Email:
Password:

Promimic appoints CEO

Magnus Larsson succeeds Ulf Brogren at the Swedish firm

Promimic Magnus LarssonGothenburg, Sweden-based Prominic, part of life science investment company Karolinska Development, has appointed Magnus Larsson as its new chief executive officer.

Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development.

He brings over 15 years of sales and marketing leadership experience in the international dental implant industry, including three years at Nobel Biocare as country manager for its Swedish business.

Tord Lendau, chairman of the board at Promimic, said: “We are pleased to welcome Magnus Larsson to the company as chief executive officer.

“Magnus brings valuable global leadership experience and a wide network from his time in the dental implant industry.”

Meanwhile, Promimic's former chief executive Ulf Brogren is relocating to the US to lead the launch of the company's North America sales operations from Austin, Texas.

Lendau added: “With this appointment and the launch of Promimic under Mr Brogren's leadership, we are now in much better position to meet our strategic commitment to our customers in North America and build our business in this important market.”

1st February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics